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PENCIRIAN MOLEKUL DAN ANALISIS BIOINFORMATIK MICRORNA-
221-5P YANG DIKAWALATUR OLEH EKSTRAK PIAWAI 
DAUN Polyalthia longifolia (Sonn.) Thwaites DI DALAM SEL HELA 
 
ABSTRAK 
Polyalthia longifolia (Sonn.) Thwaites adalah sejenis spesies tumbuhan yang 
kaya dengan nilai-nilai perubatan. Penyelidikan saintifik terkini ekstrak daripada 
daun P. longifolia telah mendedahkan sifat anti kansernya terhadap sel HeLa melalui 
pengaruhan apoptosis yang bersandarkan kaspase dengan mengawal ekspresi 
miRNA. Walau bagaimanapun, belum ada kajian dilaksanakan untuk melaporkan 
analisis fungsi mikroRNA terkawal-atur dan tiada bukti saintifik pengesahan 
pengawalan ekspresi mikroRNA dalam sel HeLa yang dirawat denagn ekstrak daun 
methanolic P. longifolia. Oleh itu, kajian ini dijalankan untuk mengesahkan ekspresi 
miRNA dalam sel HeLa yang dirawat dengan ekstrak daun P. longifolia berbanding 
dengan sel-sel HeLa kawalan yang tidak dirawat. Kajian ini telah memberi butiran 
yang khusus tentang analisis fungsian dan analisis proteomik terhadap ekspresi 
miRNA. Dalam kajian ini, ekstrak daun P. longifolia yang segar telah disediakan dan 
ujian MTT telah dilakukan untuk mengenal pasti nilai IC50 terhadap sel HeLa. 
Ekspresi miR-221-5p disahkan dengan menjalankan RTqPCR masanyata TaqMan 
yang mengesahkan regulasi penurunan ekspresi miR-221-5p dalam sel HeLa yang 
telah dirawat dengan ekstrak daun P. longifolia berbanding dengan sel yang tidak 
dirawat. Analisis fungsi miR-221-5p dilakukan dengan pendekatan mengaktifkan 
dan menyahaktifkan fungsi miRNA tersebut bersama-sama dengan menggunakan 
ujian sel pertumbuhan MTT, ujian pewarna Annexin-V FITC dan propidium iodida 




morfologi struktur ultra sel HeLa telah dikaji melalui mikroskop elektron transmisi 
(TEM), imbasan (SEM) dan mikroskop pendarfluor bagi sel yang diwarana dengan 
pewarna akridin dan propidium iodida (AO/PI). Analisis proteomik tentang protein 
yang dikawalatur oleh miR-221-5p juga dilakukan dengan dengan penggunaan LC-
ESI-MS/MS. Di samping itu, analisis bioinformatik telah dilakukan untuk mengenal 
pasti sasaran mRNA untuk miR-221-5p melalui alat bioinformatik miRGate dan gen 
ontology telah dikaji dengan penggabungan DAVID dan Enrichr serta rangkaian 
interaksi protein-protein dianalisis dengan menggunakan alat bioinformatik STRING. 
Penurunan ekspresi miR-221-5p telah disahkan dengan jayanya dalam sel HeLa yang 
dirawat dengan ekstrak daun P. longifolia. Selain itu, mekanisme molekul 
komprehensif miR-221-5p yang dikaji melalui analisis fungsi dan proteomik jelas 
menunjukkan peranan miR-221-5p dalam induksi apoptotik intrinsik yang 
bersandarkan kaspase oleh rawatan ekstrak daun P. longifolia. Memandangkan 
pengekspresan mikroRNA mengambil bahagian dalam pengawalan/ patogenesis 
kanser dan kecekapannya dalam terapeutik gen semasa yang menasarkan kanser 
sebagai pendekatan rawatan klinikal yang boleh diterima, maka ekstrak daun P. 




MOLECULAR CHARACTERIZATION AND BIOINFORMATICS 
ANALYSIS OF MICRORNA-221-5P REGULATED BY STANDARDIZED 




Polyalthia longifolia (Sonn.) Thwaites is an exquisite plant species with rich 
ethnomedicinal values. Recent scientific investigations on P. longifolia leaf extract 
have also revealed its anti-cancer property against HeLa cells through the induction 
of caspase-dependent apoptosis by regulating microRNA (miRNA) expressions. 
However, there were no further investigations performed to report the functional 
analysis of the regulated miRNA, with absolutely no means of scientific evidence of 
validation of miRNA dysregulation in HeLa cells treated with the methanolic P. 
longifolia leaf extract. Hence, this study was conducted to validate the miRNA 
expression in methanolic P. longifolia leaf extract treated HeLa cells in comparison 
with untreated HeLa cells with an intricate elucidation of functional and proteomic 
analysis of miRNA expression. In this study, methanolic P. longifolia leaf extract 
was freshly prepared and MTT assay was performed to identify the IC50 value 
against HeLa cells. The expression of miR-221-5p was validated by performing 
Taqman real time RTqPCR which confirmed the down-regulation of miR-221-5p in 
HeLa cells treated with methanolic P. longifolia leaf extract compared to the 
untreated HeLa cells. The functional analysis of miR-221-5p was conducted through 
gain-of-function and loss-of-function approach by MTT assay, flow cytometric 
analysis of Annexin V/ Propidium Iodide assay and caspase-3 assay. Besides, the 




scanning electron microscopy (SEM), transmission electron microscopy (TEM) and 
fluorescence microscopy for cells stained with acridine orange and propidium iodide 
(AO/PI). Proteomic analysis of proteins that regulated by miR-221-5p was carried 
out by LC–ESI–MS/MS. In addition, bioinformatics analysis was performed to 
identify the mRNA targets of miR-221-5p by miRGate bioinformatics tool and the 
gene ontology of the predicted genes was determined by DAVID and Enrichr 
bioinformatics tool while the protein-protein interaction network was analysed using 
STRING bioinformatics tool. Conclusively, based on the data obtained from this 
overall study, expression of miR-221-5p has been successfully validated upon P. 
longifolia leaf extract treatment in HeLa cells with its comprehensive molecular 
mechanism involved through functional and proteomic analysis which clearly 
indicated the role of miR-221-5p in the induction of caspase-dependent intrinsic 
apoptotic pathway of cell death by P. longifolia leaf extract treatment. Considering 
the participation of miRNA expression in cancer regulation/ pathogenesis and its 
efficiency in current gene therapeutic target for cancer as a clinically admissible 






CHAPTER 1: INTRODUCTION 
1.1 Overview and rationale of study 
Cells as the “building blocks of life” are well organized to balance its proliferation 
and death to ensure the proper development of healthy tissue and to get rid of the 
damaged cells, respectively (Mason and Rathmell, 2011). The coordination of the 
cell proliferation as well as the cell death mechanisms is highly important because an 
unbalanced process may lead to deadly diseases such as cancer. Cancer occurs when 
cell growth exceeds cell death due to some alteration in the cell causing them to 
multiply out of control and invade to other parts of the body. Cancer which is also 
known as malignancy or malignant neoplasm has been accounted to be one of the 
leading causes of mortality worldwide. Based on the recently published paper on 
cancer facts and figures 2019, more than 1.7 million new cancer cases are expected 
to be diagnosed and about 606, 880 deaths is expected to be recorded in United 
States of America due to cancer in 2019 (American Cancer Society, 2019).  
Cancer can be categorized based on the types of cells it occurs such as the 
carcinomas (epithelial cells), sarcoma (bone and soft tissues), leukemia (blood cells 
and bone marrow) and lymphoma (lymphocytes). Among the 100 over types of 
cancer, cervical cancer has attained an alarming health concern among women 
globally which needs a compelling prevention. Cervical cancer is the third most 
prevailing gynecologic cancer in USA which peaks in elderly women, usually in 
their 50s (Dawkins et al., 2018). In fact, 569, 847 incidences of cervical cancer and 
311, 365 deaths due to cervical cancer have been reported by world region (Bray et 




2035 which may consequently lead to challenging preventive medicine structure 
(Pilleron et al., 2019). 
Although there are few general treatments available for cervical cancer like 
radiotherapy, immunotherapy, chemotherapy and surgery; chemoprevention of 
cancer through the regulation of miRNA with the utilization of medicinal plants is 
presently being advanced in cancer therapy field. Since dysregulation of genes 
involved in the biological processes have been convincingly demonstrated to be 
associated with cancer, miRNA therapeutic approach is highly trustworthy in cancer 
treatments (Ji et al., 2017). MiRNAs are small, single stranded, non-coding RNA 
molecules of 20-22 nucleotides that control the expression of target genes by 
imperfect pairing to multiple mRNA targets. The incomplete base pairing of 
miRNAs to their mRNA targets at 3‟ UTRs causes the degradation of mRNA targets 
and subsequent down-regulation of gene expression and protein inhibition. The 
participation of miRNAs in the regulation of gene expression at post transcriptional 
level and subsequent protein translational repression (Bartel, 2004) clearly 
substantiate the major role of miRNA in diverse biological processes such as cell 
death (Xu et al., 2004) and cell proliferation (Cheng et al., 2005). Interestingly, 
various plants rich in anti-cancer bioactive compounds have been shown to regulate 
the mammalian miRNA levels (Xie et al., 2016; Gezici and Sekeroglu, 2017). 
1.2 Polyalthia longifolia as an important medicinal plant 
Polyalthia longifolia var. Angustifolia Thw. (Annonaceae) is one of the most 
important medicinal plants which is found throughout Malaysia and widely used in 
traditional medicine as febrifuge and tonic (The Wealth of India, 1969). The local 




sized tree with linear-lanceolate leaves, 1 to 1.5 cm broad, occurring in Sri Lanka 
and now grown in tropical parts of India along road sides and in gardens for their 
beautiful appearance (Bose et al., 1998). The diterpenes, alkaloids, steroid and 
miscellaneous lactones were isolated from its bark (The Wealth of India, 1969). The 
stem bark extracts and isolated compounds were studied for various biological 
activities like anti-bacterial, cytotoxicity and anti-fungal activity (Goutham et al., 
2010). Study conducted by Jothy et al. (2012) reported the anti-oxidant activity and 
hepatoprotective potential of P. longifolia. The results of this study revealed that P. 
longifolia leaf extract could protect the liver against paracetamol-induced oxidative 
damage. They also reported that the observed hepatoprotective activity of P. 
longifolia in their study might be due to its antioxidant activity, resulting from the 
presence of phenolic compounds in the extracts. Jothy et al. (2013) also tested the 
genotoxic potential of P. longifolia leaf against H2O2-radical-mediated DNA damage 
by using plasmid relation, comet, and Allium cepa assay. The results of the in vitro 
tests in their study demonstrated that P. longifolia leaf was devoid of a significant 
genotoxic effect under experimental conditions. Their Allium cepa assay results 
showed that, applied in lower concentrations, the methanol extract of P. longifolia 
leaf could be important for maintaining the genetic stability of the organism. An 
acute oral toxicity study revealed that P. longifolia leaf extract was safe after oral 
administration as a single dose to female albino Wistar rats with up to 5000 mg/kg 
body weight (Jothy et al., 2013). 
The induction of apoptosis by P. longifolia treatment has been revealed to 
cause cell cycle arrest at sub G0/G1, G0/G1 and G2/M phases as well as to increase 
the mitochondria membrane potential depolarization (Vijayarathna et al., 2017a). 




demonstrated an up-regulation of pro-apoptotic proteins and down-regulation of anti-
apoptotic proteins in HeLa cells upon P. longifolia treatment. Besides, 
morphological study through various microscopic approaches also evidently showed 
the induction of apoptosis in HeLa cells by P. longifolia leaf extract treatment based 
on typical apoptotic cell morphology observed in P. longifolia treated cells 
(Vijayarathna et al., 2017b). The most recent study showed that P. longifolia leaf 
extract induced apoptosis in HeLa cells through the regulation of miRNAs 
(Vijayarathna et al., 2017c; Vijayarathna, 2017). However, there are no further 
reports on the relationship between the cytoxicity of P. longifolia leaf extract with 
the detailed mechanism of apoptosis through miRNA deregulation in HeLa cell lines. 
There is absolutely no further validation and functional analysis of the deregulated 
miRNAs which has been previously reported. Hence, the current study was 
undertaken to validate the role of dysregulated miRNA in inducing the apoptotic cell 
death in HeLa cells and to identify their targets proteins. 
The miRNA deregulation, validation and functional analysis in HeLa cell 
treated with standardized P. longifolia leaf extract was conducted by transfection of 
miRNA mimic and anti-miR into HeLa cells to over-express and silence the miRNA 
expression, respectively. Validation of miRNA-221-5p in HeLa cells upon P. 
longifolia treatment was carried out through taqman real time RT-qPCR. Functional 
analysis of miR-221-5p in relation to P. longifolia leaf extract treatment in HeLa 
cells was carried out through MTT, annexin V/PI and caspase 3 assays. Preliminary 
study of morphology of HeLa cells upon transfection of miRNA mimic and 
treatment with methanolic P. longifolia leaf extract was accomplished using 
scanning electron microscopy (SEM), transmission electron microscopy (TEM) and 




propidium iodide (PI) dyes. The detailed proteomics analysis of miR-221-5p in 
relation to the P. longifolia treatment in HeLa cells was implemented through LC-
ESI-MS/MS mass spectrometry systems. Further bioinformatics analysis of miR-
221-5p was accomplished with the aid of various bioinformatics tools such as 
migrate (http://mirgate.bioinfo.cnio.es), The Database for Annotation, Visualization 
and Integrated Discovery (DAVID) v6.8 (https://david.ncifcrf.gov/) and a web-based 
PPI prediction tool called the STRING resource v10.5 (http://string-db.org/). Figure 
1.1 shows the workflow of the overall research. 
1.3 Objectives 
The study was conducted with the objectives: 
1. To validate the expression of miR-221-5p in HeLa cells treated with methanolic 
P. longifolia leaf extract treatment in comparison with untreated control HeLa 
cells. 
2. To study the function of miR-221-5p in inducing the apoptotic cell death in HeLa 
cells treated with standardized P. longifolia leaf extract by using miRNA mimic 
and anti-miR transfection to enhance and knock down the miRNA expression, 
respectively. 
3. To study the morphological changes in miR-221-5p and miR-484 regulated 
HeLa cells, alongside with P. longifolia leaf extract treatment.  
4. To investigate the role of miRNAs and their targets in Hela cells to induce 
apoptotic cell death after treatment with standardized P. longifolia leaf extract 
using bioinformatics approaches. 
5. To identify the target apoptotic related proteins of miR-221-5p in HeLa cells 











CHAPTER 2: LITERATURE REVIEW 
2.1 Cancer 
Genetically programmed cell division and differentiation occur in the process of 
formation of specific tissues and eventually functional organs. However, 
intermittently the uncontrollable cell division may give rise to tissue masses called 
tumors, or neoplasms. A single mass of benign tumor is usually not life threatening 
since it can be cured completely by surgical removal. However, when the cells of a 
tumor start to invade and interrupt the surrounding tissues, the tumor is said to be 
malignant and is identified as cancer which can consequently lead to death due to 
injury to vital organs, secondary infection, metabolic problems, secondary 
malignancies, or hemorrhage. The place where cancer begins is known as the 
original or primary site. A malignant tumor can break away from its original location 
and invade far-away sites through the lymphatic system, forming new tumors. This 
process is known as metastasis. The uncontrollable growth of cells may occur in any 
parts of the body leading to more than 100 types of cancer including lung cancer, 
breast cancer, cervical cancer, stomach cancer, prostate cancer, bowel cancer and 
ovarian cancer.  
 According to the American Cancer Society (2019), risk factors for cancer 
include genetic factors such as inherited genetic mutations and immune conditions as 
well as the lifestyle of a person such as tobacco use, alcohol use, diet, and physical 
activity. Other disposing factors to cancer are certain type of infections such as 
human papilloma virus (HPV), Epstein-Barr virus (EBV), hepatitis B, hepatitis C 
and Helicobacter pylori. Environmental exposures to diverse range of chemicals, 




lead to cancer. Smoking and alcohol intake can be associated with several cancers 
such as the mouth, oral cavity, pharynx, larynx, esophagus, lung, stomach, pancreas 
and even colon (Schmidt and Popham, 1981). Besides, viral infection can be related 
to cancer because of their capability to integrate into the DNA of the human stem 
cell where it mutates and transforms the cell to be the parent of the malignant clone 
(Doll and Peto, 1981). 
 
2.1.1 Current development in cancer therapy 
There are several types of treatments available for cancer including surgery, 
radiation therapy, chemotherapy, immunotherapy, gene therapy, hyperthermia, and 
stem cell transplant. However, these treatments have excruciating side effects that 
vary from person to person depending on the frequency of treatment, the age of the 
person and other health conditions. Commonly occurring side effects generated by 
cancer treatments include anemia, alopecia (hair loss), constipation, edema, fatigue, 
memory problems, peripheral neuropathy, nausea and vomiting (National Cancer 
Institute, 2018; Wilkes, 2018). Chemotherapy is one of the popular cancer treatments 
fromthe 1960s as the degree of curing cancer elevated at approximately 33% through 
radical local treatments. Eventually Cancer Chemotherapy National Service Centre 
was established in the effort of developing methods to screen chemicals using 
transplantable tumors in rodents (Devita and Chu, 2008). 
The evolving knowledge on cancer mechanisms has expedited the expansion 
of novel anticancer approaches. One of the most extensive conventions is to slow 
down or to inhibit the prime characteristic of cancer cells that grow uncontrollably. 
This can be correlated with the elevation of tendency of the cells to go through the 




through a mechanistic manner where the cytotoxic drugs are designed so as to 
impede the DNA replication by damaging the DNA of the cancer cells, subsequently 
inducing apoptosis. 
Crude extracts from plant samples have been established to be selectively 
toxic to cancer cells after passing through various bioassays including in vitro and in 
vivo screenings which led to the plant collection program by the United States 
National Cancer Institute (NCI), followed by screening of plant species for 
anticancer activity which resulted in a revelation of enormous number of new 
anticancer agents such as taxanes and camptothecin (Cassady and Douros, 1980; 
Shoeb, 2006). Plants rich in pytochemicals such as berberine, curcumin, genistein, 
daidzein, glyceollin, apigenin, quercetin, baicalein, resveratrol, luteolin, matrine, 
garcinol, silibinin, mangiferin, doxorubicin, and paclitaxel have been evidently to 
demonstrated to exhibit anti-cancer property by participating in biological processes 
including cell differentiation, proliferation and apoptosis (Sala-Cirtog et al., 2015; 
Biersack, 2016; Devi et al., 2017). The recent evolution of miRNA investigations 
and its involvement in regulating biological processes such as cell proliferation, and 
migration, metastasis,apoptosis, and cell differentiation in numerous malignancies by 
partial complementary binding to mRNA targets (Sethi et al., 2013; Thakur et al., 
2014). This has led to a viewpoint concerning to associate phytochemical-rich 
medicinal plants to regulate the expression of miRNAs involved in tumorogenesis. 
Regulation of miRNA expression by medicinal plant extracts has become a 
promising novel strategy for cancer treatment, exclusively through inducing 






2.2 Polyalthia longifolia 
Polyalthia longifolia from Annonaceae family is well known for its sophisticated 
traditional medicinal values. Polyalthia longifolia (Sonn.) Thwaites commonly 
known as False Ashoka, Buddha Tree, Green champa, Indian mast tree, and Indian 
Fir tree while its synonyms include Uvaria longifolia (Sonn.), Guatteria longifolia 
(Sonn.) Wallich, Unona longifolia (Sonn.) (Jothy et al., 2013). Polyalthia longifolia 
indegeneously belongs to Sri Lanka and cultivated in Pakistan which is now widely 
found throughout Malaysia. The classification of P. longifolia is as follows: 
Kingdom : Plantae 
Division : Magnoliophyta 
Class : Magnoliopsida 
Subclass : Magnoliidae 
Order : Mognoliids 
Family : Annonaceae 
Tribe : Annoneae 
Genus : Polyalthia 
Species : longifolia 
 
2.2.1 Botanical description of P. longifolia 
The evergreen pyramid-like P. longifolia trees are known to grow tall upto an 
altitude of 15 to 20 m. Its dark green glossy leaves are seen to be long and narrow 
approximately acounting to 7.5-23 by 1.5-3.8 cm (Katkar et al., 2010). The ovate-
oblong leaves with wavy margins possess mild fragrance while the mildly pale green 
flowers with wavy petals are non-fragrant (Lemmens and Bunyapraphatsara, 2003). 




seed. The P. longifolia trees generally bear flowers and fruits during the month of 
February till June (Wallis, 1985; Yadav and Sardesai, 2000). 
 
2.2.2 Pharmacological activities of P. longifolia 
The pharmacological properties of P. longifolia include anti-microbial, anti-oxidant, 
anti-cancer, anti-proliferative, radioprotective, anti-inflammatory, and anti-ulcer 
(Dixit et al., 2014).  
 
2.2.2(a) Anti-microbial activity 
Polyalthia longifolia leaves extracted using different solvents have been 
comparatively tested for anti-microbial activity against microbes such as Bacillus 
subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus 
vulgaris and Salmonella typhi through disc-diffusion method which evidently 
demonstrated the potential anti-bacterail activity of P. longifolia leaf extract 
(Thenmozhi and Sivaraj, 2010). In another study, methanolic leaf extract of P. 
longifolia was shown to exhibit anti-bacterial activity against Bacillus subtilis and 
Staphylococcus aureus reporting diameter of inhibition zones 24 mm and 22.6 mm, 
respectively (Uzama et al., 2011). In addition, various bioactive components 
diterpenoids, alkaloids and allantoin isolated from the different parts of P. longifolia 
have also reported to exert significant anti-bacterial and anti-fungal activities against 
Aspergillus fumigatus, Saccharomyces caulbequence, Saccharomyces cerevaceae, 
Candida albicans, and Hensila californica (Rashid et al., 1996; Faizi et al., 2003; 






2.2.2(b) Anti-oxidant activity 
In vitro anti-oxidant activity of ethyl acetate and methanolic P. longifolia seed 
extracts by DPPH, nitric oxide radical, hydroxyl radical, and superoxide radical 
considering ascorbic acid as standard have been successfully demonstrated by 
Thonangi and Akula (2018) which was further correlated with total phenolic content 
assay reporting 114 ± 1.7 and 146.5 ± 2.4 mg/g gallic acid equivalents respectively. 
Another study also reported the anti-oxidant potential of P. longifolia stem bark 
ethanol extract by analysing the DPPH radicals scavenging effect, ferric ions 
reduction effect and lipid peroxidation inhibition with IC50 values of 18.14, 155.41 
and 73.33 µg/mL, respectively (Manjula et al., 2010). In vitro antioxidant activity of 
methanolic P. longifolia leaf extract was shown by inhibition of DPPH radical at 
IC50 value of 2.721 ± 0.116 mg/mL (Jothy et al., 2012). 
 
2.2.2(c) Anti-cancer activity 
Ethanolic Polyalthia longifolia leaf extract was evidently shown to exhibit anti-
cancer activity by inhibiting cell viability of several human cancers including colon 
cancer, liver cancer, prostate cancer, neuroblastoma, with a highest anti-cancer effect 
on colon cancer cells SW-620 accounting an IC50 value 6.1 μg/ml (Verma et al., 
2008). Another study reported the anti-cancer activity of Polyalthia longifolia stem 
bark ethanol extract against HeLa and MCF-7 cells with IC50 values of 25.24 and 
50.49 µg/mL, respectively (Manjula et al., 2010). Recent study conducted by 
Vijayarathna et al. (2017a) revealed the anti-cancer activity of standardized 
methanolic Polyalthia longifolia leaf extract against HeLa cells through MTT assay 




2.3 Plant extraction methods 
Plants are highly utilized pharmaceutically due to the rich medicinal values of their 
phytochemicals such as phenolics and flavonoids. Various plant extraction methods 
are widely practiced in galenical development such as the maceration method 
(Figure 2.1 A), soxhlet extraction method (Figure 2.1 B) and ultrasound extraction 
method (Figure 2.1 C). 
 
2.3.1 Maceration 
Maceration is a well-established plant extraction method which involves soaking of 
the coarse powdered plant material in a closed vessel with an appropriate solvent 
(Jones and Kinghorn, 2006; Handa et al., 2008). The selection of solvent mainly 
depends on the bioactive compounds of interest from the plant material and thus the 
solubility of the compounds in the selected solvent is important to be taken into 
account while choosing an appropriate solvent. In addition, chemical 
characterization of the solvent and extraction yield is also equally imperative to 
consider while choosing a solvent for the plant extraction through maceration 
method. Commonly used solvents for the maceration process include hexane, 
chloroform, ethyl acetate, methanol or ethanol (Yan et al., 2008). The maceration 
process is usually carried out at room temperature for at least three days with 
occasional agitation to allow the solubilisation of phytochemicals from the plant 
material. The mixture is then filtered and the final marc is pressed out to completely 










Figure 2.1: Different types of plant extraction methods 







2.3.2 Soxhlet extraction 
Soxhlet extraction, also known as the Hot Continuous Extraction was developed by 
van Soxhlet in 1879 (Soxhlet, 1879). The finely powdered plant material is placed in 
a “thimble” which is usually attributed from a strong filter paper or cellulose. The 
sample containing “thimble” is placed in the thimble-holder of the soxhlet extractor 
while the extraction solvent is filled in the distillation flask at the bottom. When the 
solvent is heated, the vapourized solvent is condensed and consecutively fills the 
thimble containing the plant material. When the solvent level rises, a siphon tube 
aspirates it from the thimble-holder and discharges it back into the distillation flask. 
This process is continued until the solvent from the siphon tube does not leave 
residue when evaporated and thus, it is a continuous–discrete plant extraction 
method (Luque de Castro and Priego-Capote, 2010).  
 
2.3.3 Ultrasound extraction or sonication extraction 
This extraction method comprises the utilization of ultrasound with frequencies 
ranging from 20 kHz to 2000 kHz (Handa et al., 2008). The acoustic effect from the 
ultrasound causes produces cavitation which in turn increases the permeability of the 
cell wall promoting the release of phytochemicals from the plant material into the 
solvent. Although this extraction method is easy and cost-effective, higher 







Small endogenous RNA molecules can be classified into several types, including 
transfer RNA (tRNA), ribosomal RNA (rRNA), small nucleolar RNA (snoRNA), 
small interfering RNA (siRNA) and micro RNA (miRNA). The endogenous small 
miRNA molecules which are approximately 20-22 nucleotides long are derived from 
the double stranded RNA precursor molecules (Ketting, 2010). The breakthrough of 
miRNA was first discovered in Caenorhabditis elegans and the disclosure of small 
non-coding lin-4 transcript from C. elegans which was 22 nucleotides long found to 
down regulate LIN-14 protein expression via sequence complementary binding to 3‟ 
untranslated region (UTR) of lin-14 mRNA (Lee et al., 1993). Since then, miRNA 
has attained an increasing deliberation and led to detailed investigation of miRNA 
biogenesis and function in the advancement of molecular biology. Contemporarily, 
28645 distinguish hairpin precursor miRNA, expressing 35828 mature miRNA from 
223 species have been identified (Griffiths-Jones, 2004; Griffiths-Joneset al., 2006; 
Griffiths-Jones et al., 2008; Kozomara and Griffiths-Jones, 2011; Kozomara and 
Griffiths-Jones, 2014) (http://www.mirbase.org/ accessed March 10, 2018). This 
arising principal class of regulatory genes have been identified by bioinformatics 
prediction approaches and validated through several experimental methods. The 
involvement of miRNA in the negative regulation of gene expression at post 
transcriptional level and subsequent protein translational repression (Bartel, 2004) 
clearly substantiate the major role of miRNA in diverse biological processes such as 
cell death (Xu et al., 2004), cell proliferation (Cheng et al., 2005), cell development 
(Yoo and Greenwald, 2005), cell differentiation (Naguibneva et al., 2006), stress 
resistance (Dresios et al., 2005), haematopoiesis (Garzon et al., 2006), fat 




2004). Hence, the evolution of miRNA has exposed a novel and attractive 
therapeutic target and diagnostic tool for various diseases including cancer. 
 
2.4.1 MicroRNA biogenesis 
In like manner of precursor mRNA synthesis, miRNA are also generated by RNA 
polymerase II by initially producing a lengthy transcript called the primary miRNA 
(pri-miRNA) (Bartel, 2004). The pri-miRNA transcripts have been evidently 
validated to possess 5‟ cap and poly (A) tail at 3‟ end as any other typical mRNA 
(Cai et al., 2004; Lee et al., 2004). Previous studies suggest that the length of pri-
miRNA transcript can be approximately 1000 nucleotide (Lee et al., 2003; Cai et al., 
2004). Considering the length of pri-miRNA is pretty long with complementary 
bases within the transcript, it is legitimate to form a partially paired stem-loop 
structure (Treiber et al., 2012). This structure acts as substrate for RNase III class of 
enzymes, namely DROSHA and Di George Syndrome critical region gene 8 
(DGCR8) which eventually recognises the hairpin-loop structure of pri-miRNA and 
catalyzes it into a short precursor miRNA (pre-miRNA) (Denli et al., 2004; Gregory 
et al., 2004; Landthaler et al., 2004). This first cleavage process is initiated by the 
binding of the microprocessor complex (complex of DROSHA and DGCR8) to the 
open-ended part of the stem-looped miRNA and finally the double-stranded cleavage 
produces a concise hair-pin shaped RNA molecule with a two nucleotide over hang 
at the 3‟ end (Han et al., 2004; Han et al., 2006). The double stranded stem-loop 
structure of pre-miRNA has been identified to be approximately 70-100 bp long 
(Treiber et al., 2012).  
 Subsequently, the transportation of pre-miRNA from nucleus to the 




al., 2003; Lund et al., 2004). Previous studies demonstrated that the Exportin 5 
performs its role as nuclear cargo with the aid of RanGTP in which stable complexes 
of pre-miRNA·Exportin 5·RanGTP are productively exported to cytoplasm down the 
RanGTP gradient across the nuclear envelope and pre-miRNA and Exportin 5 are 
dissociated upon the hydrolysis of RanGTP to RanGDP in cytoplasm (Bohnsack et 
al., 2004). The free Exportin 5 is then returned back to the nucleus to mediate new 
pre-miRNA exportation.  
 Instantaneously, the second cleavage in the biogenesis process of miRNA 
takes place in the cytoplasm by RNase III enzyme called the DICER (Grishok et al., 
2001; Ketting et al., 2001). DICER incorporates PAZ (Piwi, Arganoate and Zwille) 
domain that binds to the two nucleotide 3‟ overhang and anchors the pre-miRNA in 
position while placing the stem loop terminal at the positively charged catalytic 
domain of the DICER (Macrae et al., 2006; MacRae et al., 2007). This arrangement 
enables the DICER to act as a molecular ruler, thereby assisting the cleavage to 
occur efficiently at approximately 65 angstrom (Å) from PAZ domain and cleaves 
off the loop from the pre-miRNA (MacRae et al., 2007; Ketting, 2010; Park et al., 
2011). The subsequent shorter double stranded RNA of about 20-25 nucleotides in 
length, with two nucleotide 3‟ overhangs at both terminals is known as miRNA 
duplex or miRNA/miRNA* (MacFarlane and Murphy, 2010). 
 miRNA duplex is then loaded into the miRNA-Induced Silencing Complex 
(miRISC) and releases one of the strand while selectively bound to one strand in 
order to generate an active complex (Bartel, 2004). The strand which is integrated 
into the miRISC is termed as the guide strand (miRNA) while the strand which is 
released and degraded is termed as the passenger strand (miRNA*). The Argonaute 




The Argonaute protein comprises two essential domains, namely PAZ and PIWI. 
The PAZ domain has been demonstrated to bind to the backbone of the guide strand 
(Song et al., 2003; Ma et al., 2004) while the PIWI domain acts as the RNase H 
which breaks down the passenger strand (Martinez and Tuschl, 2004; Song et al., 






Figure 2.2: Overview of miRNA biogenesis process 
(Source: Lin and Gregory, 2015) 
Abbreviation: RNA polymerase II (Pol II), Primary microRNA (pri-miRNA), Di 
George Syndrome critical region gene 8 (DGCR8), Precursor microRNA (pre-





2.4.2 MicroRNA and cancer 
Ever since the exploration of miRNA and its‟ correlation with the widespread 
biological processes mainly including apoptosis and cell proliferation, the 
fundamental significance of miRNA in tumorigenesis are strongly postulated. 
Henceforth, the miRNA-mediated molecular mechanism in cancer biology has 
unfastened a novel dimension for cancer therapeutic targets as well as cancer 
biomarkers. The miRNA binds to its target mRNA by partial complementary binding, 
thus silences the gene expression and represses the post translational activity. The 
means of function of miRNA via alteration of gene expression and consecutive 
translational expression, pinpoints that miRNAs can act as tumor suppresser genes or 
oncogenes depending on their target genes (Kent and Mendell, 2006; Zhang et al., 
2007).  
For instance, up-regulation of specific miRNA targeting the tumor suppressor 
genes, eventually, promoting cell growth and cancer initiation acts as an oncogene. 
On the other hand, up-regulation of specific miRNA targeting genes responsible for 
oncogenic activities which ultimately lead to cancer inhibition or repression acts as 
tumor suppressor gene (Shenouda and Alahari, 2009). However, the up-growing 
investigations on miRNA have uncovered the dual role of miRNA in cancer, in 
which various evidence supports the concept that a same individual miRNA can act 
as both oncogene and tumor-suppressor gene depending on the cellular environment 
(Schetter et al., 2012; Sharma et al., 2014; Ding et al., 2018). Based on the literature, 
extensive studies have reported the correlation between miRNAs and cancer to date 





2.4.2(a) Mechanisms involved in microRNA deregulation in cancer 
The dysregulation of miRNAs in cancer occur through numerous overlapping 
mechanisms including chromosomal abnormalities, transcriptional control alterations, 
epigenetic modulation and disruption in the miRNA processing machinery (Peng and 
Croce, 2016). For instance, chromosomal alterations may occur due to amplification 
of a chromosome site harbouring a specific miRNA, leading to an over-expression of 
the particular miRNA (Hayashita et al., 2005; Tagawa and Seto, 2005) while 
deletion of the chromosome site may result in down-regulation of the specific 
miRNA (Calin et al., 2002; Calin and Croce, 2006).  
Other than that, various transcriptional factors have been evidently reported 
to control the expression of miRNAs such as c-Myc (Chang et al., 2008; Han et al., 
2013), p53 (He et al., 2007; Hermeking, 2010), myeloid transcription factors PU.1 
and C/EBPs (Fukao et al., 2007) and transcription factors NFI-A and C/EBPα (Fazi 
et al., 2005). Besides, miRNAs have also been reported to undergo epigenetic 
changes through CpG methylation (Fazi et al., 2007), DNA methylation with histone 
acetylation inhibitors (Saito et al., 2006), and hypermethylation (Lujambio et al., 
2008; Lehmann et al., 2008).  
Finally, dysregulation or mutation of any proteins involved in miRNA 
biogenesis process as described in section 2.1.1 such as DROSHA (Thomson et al., 
2006), DGCR8 (Walz et al., 2015), Dicer (Kumar et al., 2009; Iliou et al., 2014), 
Argonaute proteins (Zhang et al., 2013; Völler et al., 2013), TRBP (Melo et al., 





2.4.2(b) Pathways involved in microRNA regulation in cancer  
The current chemotherapy targeting miRNA is hugely attaining interest due 
to their important participation in cancer pathway. Numerous miRNAs were also 
evidently shown to regulate tumor necrosis factor (TNF)-related apoptosis-inducing 
ligand (TRAIL)-induced apoptosis pathway. Based on the research conducted by 
Garofalo et al. (2008), over-expression of miR-221 and miR-222 was shown to 
hinder the TRAIL-induced apoptosis in non-small cell lung cancer by suppressing 
the important apoptotic protein expressions as well as targeting the tumor suppressor 
p27
kip
mRNAs. The up-regulation of miR-221 and miR-222 was also demonstrated to 
be over-expressed, leading to the down-regulation of tumor suppressor p27
kip
 in 
prostate carcinoma (Galardi et al., 2007) and melanoma (Felicetti et al., 2008).  
Besides, the involvement of miR-21 regulation in AKT-dependent pathway 
was also reported to inhibit apoptosis by directly targeting and eventually repressing 
the expression of FasL (Sayed et al., 2010). Another example of miRNA to be 
participating in Fas-mediated apoptotic pathway is miR-24 which was shown to 
target Fas-binding pro-apoptotic protein, namely Fas-associated factor 1 (FAF1), 
leading to inhibition of apoptosis in different types of cancer (Qin et al., 2010; 
Schickel et al., 2010). Another cancer pathway, namely the phosphatase and tensin 
homologue (PTEN) pathway was also shown to be regulated by the expression of 
miRNAs. For instance, many miRNAs are reported to target and suppress the 
expression PTEN which is one of the prominent tumor suppressor genes such as 
miR-17-5p (Xiao et al., 2008), miR-19305p (Xiao et al., 2008), miR-2127 (Sayed et 




 There are various microRNAs which have been reported to regulate the cell 
cycle regulatory pathway, in which oncogenic microRNAs tend to expedite cell 
cycle progression while the microRNAs with tumor suppressor effect tend to 
facilitate cell cycle arrest. Exemplary oncogenic microRNA include miR-106b and 
miR-17-92 families which have been reported to be over-expressed in various 
cancers are known to target one of the important inducer of G1 arrest, namely p21 
from the Cip/Kip family of CDK inhibitors (Ivanovska et al., 2008; Kim et al., 2009). 
Other studies have also experimentally validated numerous other miRNAs to target 
other genes involved in cell cycle which eventually regulate the RAS/RAF/MAPK 
pathway as well as the p53 pathway (Jansson and Lund, 2012). Furthermore, 
microRNAs are also very well known to target numerous genes involved in DNA 
damage response in cancer cells. For instance, miR-421 was reported to be highly 
over-expressed in neuroblastoma and B-cell lymphoma cell lines and was shown to 
target the apical damage sensor kinase ATM (Hu et al., 2010).  
 
2.4.3 MicroRNA and medicinal plants  
Endogenous microRNAs (miRNAs) are short single-stranded RNA molecules that 
cause mRNA cleavage or translational repression through partial complementary 
binding to the 3‟ untranslated region (UTR) of specific protein coding mRNAs (Ling 
et al., 2013). This plays important role in regulation of various biological activities, 
thus leading to the break thorough of miRNA-based therapeutic approaches for 
several diseases. As medicinal plants are highly utilized in the treatment of diseases 
for centuries due to its rich bioactive phytochemicals, the understanding of its 
mechanistic actions in regulating the miRNA expressions has recently drawn an 
